Item 9 Labs Corp. (INLB)
OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: Jul 9, 2025
Item 9 Labs Income Statement
Financials in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
Fiscal Year | TTM | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '23 Jun 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 | Sep '19 Sep 30, 2019 | Sep '18 Sep 30, 2018 | 2017 |
| 19.69 | 21.76 | 21.94 | 8.12 | 4.93 | 1.4 | Upgrade | |
Revenue Growth (YoY) | -17.44% | -0.82% | 170.10% | 64.61% | 251.96% | 449.59% | Upgrade |
Cost of Revenue | 9.89 | 14.45 | 13.32 | 4.83 | 2.56 | 1.02 | Upgrade |
Gross Profit | 9.8 | 7.31 | 8.61 | 3.3 | 2.38 | 0.38 | Upgrade |
Selling, General & Admin | 17.91 | 18.83 | 12.89 | 5.79 | 4.86 | 0.75 | Upgrade |
Other Operating Expenses | 0.52 | - | - | 1.48 | 0.85 | 0.28 | Upgrade |
Operating Expenses | 19.85 | 20.43 | 14.21 | 8.62 | 6.76 | 1.04 | Upgrade |
Operating Income | -10.04 | -13.12 | -5.6 | -5.33 | -4.38 | -0.65 | Upgrade |
Interest Expense | -9.2 | -6.41 | -5.3 | -6.96 | -0.34 | -0 | Upgrade |
Interest & Investment Income | - | - | - | - | 0.07 | 0.03 | Upgrade |
Other Non Operating Income (Expenses) | 0 | 0 | -0.01 | 0 | 0.46 | - | Upgrade |
EBT Excluding Unusual Items | -19.24 | -19.53 | -10.91 | -12.29 | -4.19 | -0.62 | Upgrade |
Impairment of Goodwill | - | - | - | - | -4.8 | - | Upgrade |
Gain (Loss) on Sale of Investments | - | - | - | -0.1 | - | - | Upgrade |
Gain (Loss) on Sale of Assets | -9.54 | -9.54 | - | - | - | - | Upgrade |
Asset Writedown | -0.58 | -0.41 | - | - | -0.96 | - | Upgrade |
Other Unusual Items | -1.69 | -1.69 | - | - | - | - | Upgrade |
Pretax Income | -31.04 | -31.17 | -10.91 | -12.39 | -9.95 | -0.62 | Upgrade |
Income Tax Expense | 0.01 | 0.01 | - | -0.09 | - | 0.09 | Upgrade |
Earnings From Continuing Operations | -31.05 | -31.18 | -10.91 | -12.3 | -9.95 | -0.71 | Upgrade |
Earnings From Discontinued Operations | - | - | - | - | - | 0.02 | Upgrade |
Net Income to Company | -31.05 | -31.18 | -10.91 | -12.3 | -9.95 | -0.69 | Upgrade |
Minority Interest in Earnings | 0.02 | 0.04 | - | 0.03 | 0.12 | - | Upgrade |
Net Income | -31.03 | -31.14 | -10.91 | -12.27 | -9.82 | -0.69 | Upgrade |
Net Income to Common | -31.03 | -31.14 | -10.91 | -12.27 | -9.82 | -0.69 | Upgrade |
Shares Outstanding (Basic) | 100 | 96 | 79 | 62 | 62 | 32 | Upgrade |
Shares Outstanding (Diluted) | 100 | 96 | 79 | 62 | 62 | 32 | Upgrade |
Shares Change (YoY) | 3.58% | 21.75% | 27.54% | 0.15% | 90.34% | 329.94% | Upgrade |
EPS (Basic) | -0.31 | -0.33 | -0.14 | -0.20 | -0.16 | -0.02 | Upgrade |
EPS (Diluted) | -0.32 | -0.33 | -0.14 | -0.20 | -0.16 | -0.02 | Upgrade |
Free Cash Flow | -2.6 | -6.58 | -8.23 | -1.31 | -8.4 | -1.31 | Upgrade |
Free Cash Flow Per Share | -0.03 | -0.07 | -0.10 | -0.02 | -0.14 | -0.04 | Upgrade |
Gross Margin | 49.79% | 33.61% | 39.26% | 40.58% | 48.19% | 27.37% | Upgrade |
Operating Margin | -51.01% | -60.30% | -25.53% | -65.58% | -88.82% | -46.64% | Upgrade |
Profit Margin | -157.61% | -143.14% | -49.71% | -151.12% | -199.12% | -49.13% | Upgrade |
Free Cash Flow Margin | -13.19% | -30.25% | -37.52% | -16.11% | -170.25% | -93.63% | Upgrade |
EBITDA | -8.46 | -11.35 | -4.38 | -4.42 | -4.08 | -0.6 | Upgrade |
EBITDA Margin | -42.96% | -52.17% | -19.97% | -54.40% | -82.62% | -43.09% | Upgrade |
D&A For EBITDA | 1.58 | 1.77 | 1.22 | 0.91 | 0.31 | 0.05 | Upgrade |
EBIT | -10.04 | -13.12 | -5.6 | -5.33 | -4.38 | -0.65 | Upgrade |
EBIT Margin | -51.01% | -60.30% | -25.53% | -65.58% | -88.82% | -46.64% | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.